News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
298,942 Results
Type
Article (15609)
Company Profile (289)
Press Release (283044)
Section
Business (90436)
Career Advice (475)
Deals (14991)
Drug Delivery (39)
Drug Development (52352)
Employer Resources (72)
FDA (6297)
Job Trends (6296)
News (160939)
Policy (12126)
Tag
Academia (1150)
Alliances (24823)
Alzheimer's disease (855)
Approvals (6284)
Artificial intelligence (111)
Bankruptcy (123)
Best Places to Work (5596)
Biotechnology (236)
Breast cancer (129)
Cancer (1118)
Cardiovascular disease (87)
Career advice (414)
CAR-T (89)
Cell therapy (257)
Clinical research (42048)
Collaboration (447)
Compensation (172)
COVID-19 (1117)
C-suite (113)
Cystic fibrosis (76)
Data (1125)
Diabetes (108)
Diagnostics (1618)
Earnings (32401)
Events (52799)
Executive appointments (352)
FDA (6807)
Funding (417)
Gene editing (75)
Gene therapy (195)
GLP-1 (364)
Government (1434)
Healthcare (8339)
Infectious disease (1167)
Inflammatory bowel disease (101)
Interviews (74)
IPO (7985)
Job creations (1007)
Job search strategy (371)
Layoffs (218)
Legal (2110)
Lung cancer (171)
Lymphoma (74)
Manufacturing (110)
Medical device (3472)
Medtech (3473)
Mergers & acquisitions (7246)
Metabolic disorders (318)
Neuroscience (1169)
NextGen: Class of 2025 (2792)
Non-profit (1674)
Northern California (1319)
Obesity (171)
Opinion (119)
Parkinson's disease (91)
Patents (82)
People (28717)
Phase I (14751)
Phase II (19474)
Phase III (12429)
Pipeline (499)
Postmarket research (967)
Preclinical (6136)
Radiopharmaceuticals (209)
Rare diseases (251)
Real estate (1722)
Regulatory (9473)
Research institute (1139)
Series A (77)
Southern California (1182)
Startups (2099)
United States (10821)
Vaccines (204)
Weight loss (99)
Date
Today (13)
Last 7 days (375)
Last 30 days (1592)
Last 365 days (21982)
2025 (2106)
2024 (22176)
2023 (24259)
2022 (29170)
2021 (30743)
2020 (27002)
2019 (20852)
2018 (15143)
2017 (15328)
2016 (13510)
2015 (16165)
2014 (11641)
2013 (8427)
2012 (8642)
2011 (8853)
2010 (8362)
Location
Africa (226)
Asia (19428)
Australia (3161)
California (3040)
Canada (1041)
China (281)
Colorado (114)
Connecticut (144)
Europe (39885)
Florida (365)
Georgia (97)
Illinois (224)
Indiana (84)
Maryland (439)
Massachusetts (2381)
Minnesota (137)
New Jersey (772)
New York (860)
North Carolina (508)
Northern California (1319)
Ohio (100)
Pennsylvania (572)
South America (297)
Southern California (1182)
Texas (364)
Washington State (298)
298,942 Results for "engage therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
Press Releases
Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell Engager
January 7, 2025
·
3 min read
Press Releases
Nona Biosciences Announces Discovery Collaboration with Candid Therapeutics for Next-Generation T-Cell Engagers
December 16, 2024
·
2 min read
Pharm Country
LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
LAVA Therapeutics N.V. today announced that Stephen Hurly, President and Chief Executive Officer of LAVA Therapeutics, will present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference.
June 20, 2024
·
1 min read
Press Releases
Candid Therapeutics and Ab Studio Enter Into Research Collaboration to Discover and Develop Novel T Cell Engagers for Autoimmune Indications
December 16, 2024
·
2 min read
Press Releases
Candid Therapeutics and EpimAb Biotherapeutics Enter Into Research Collaboration to Discover and Develop Novel T-Cell Engagers for Autoimmune Indications
December 16, 2024
·
2 min read
Press Releases
NanoViricides Engages CRO for Phase II Clinical Trial
January 27, 2025
·
9 min read
Press Releases
Hera BioLabs Increases Scientific Transparency and Engagement With Bioz Technology
January 29, 2025
·
2 min read
Press Releases
Know Labs Technology Licensing (KTL) Announces Formalized Client Engagement
February 6, 2025
·
7 min read
Biotech Bay
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a fireside chat at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference on Tuesday, June 25, 2024, at 2:00 p.m. ET.
June 18, 2024
·
2 min read
1 of 29,895
Next
